| ||
|
||
|
2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one ("BMS-186295"; "SR-47436") [138402-11-6] 1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide ; Irbesartan Metabolite "SR-49498" [CAS # 748812-53-5] 2-Butyl-3-[[4-[2-(2-trityl-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one [CAS # 138402-10-5] 2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride [CAS # 151257-01-1] 5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1H-tetrazole [CAS # 124750-51-2] | ||
|
Patented products are only available for R&D use as permitted under CFR 35 Section 271(e)(1).
Copyright © All Rights Reserved. MOLCAN CORPORATION, Canada, Tel. 905-731-5537, Fax 905-248-3843, E-Mail: contact@molcan.com |